Olanzapine in the treatment of post-traumatic stress disorder: A pilot study

International Clinical Psychopharmacology

Volumn 16, Issue 4, 2001, Pages 197-203

  Butterfield, Marian I ^a,b   Becker, M E ^b   Connor, K M ^a   Sutherland, S ^a   Churchill, L E ^a   Davidson, J R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Atypical antipsychotic; Olanzapine; Post traumatic stress disorder (PTSD); Psychopharmacology

Indexed keywords

OLANZAPINE; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0034956343     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200107000-00003     Document Type: Article

References (56)

1. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder
2. Cognitive-behavioral therapy, imipramine or their combination for panic disorder
3. A rating scale for drug-induced akathisia
4. Olanzapine: A serotonindopamine-receptor antagonist for antipsychotic therapy
5. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence
6. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial
7. Placebo effect in posttraumatic stress disorders
8. Does stress damage the brain?
9. In vitro and in vivo biochemistry of olanzapine: A novel, atypical antipsychotic drug
10. Psychobiologic mechanisms of posttraumatic stress disorder
11. The role of serotonin in posttraumatic stress disorder: Neurobiology and pharmacotherapy
12. A pilot study of mirtazapine in post-traumatic stress disorder
13. Predictors of treatment response in patients with posttraumatic stress disorder
14. Fluoxetine in post-traumatic stress disorder
15. Biological therapies for posttraumatic stress disorder: An overview
16. The eight-item treatment-outcome post-traumatic stress disorder scale: A brief measure to assess treatment outcome in post-traumatic stress disorder
17. Treatment of posttraumatic stress disorder with amitriptyline and placebo
18. Fluoxetine in post-traumatic stress disorder
19. Assessment of a new self-rating scale for posttraumatic stress disorder
20. Structured interview for PTSD (SIP): Psychometric validation for DSM-IV criteria
21. Response characteristics to antidepressants and placebo in post-traumatic stress disorder
22. Treatment of posttraumatic stress disorder with nefazodone
23. D-Fenfluramine challenge in posttraumatic stress disorder
24. Nefazodone treatment for chronic posttraumatic stress disorder: An open trial
25. Use of thioridazine in post-traumatic stress disorder
26. Olanzapine and the new generation of antipsychotic agents: Patterns of use
27. Olanzapine
28. Open trial of nefazodone for combat-related posttraumatic stress disorder
29. Lack of efficacy for fluoxetine in PTSD: A placebo controlled trial in combat veterans
30. Impact of event scale: A measure of subjective stress
31. A review of the psychobiology and pharmacotherapy of posttraumatic stress disorder
32. Posttraumatic stress disorder in the National Comorbidity Survey
33. Gender differences in treatment response to sertraline versus imipramine in chronic depression
34. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imiprimine
35. Placebo effect in posttraumatic stress disorders
36. Risperidone as an adjunct therapy for post-traumatic stress disorder
37. Risperidone in PTSD
38. Atypical antipsychotics: Part I. Pharmacology, pharmacokinetics, and efficacy
39. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder
40. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder
41. Olanzapine: A new atypical antipsychotic drug
42. Risperidone effects on irritable aggression in posttraumatic stress disorder
43. Methodology of measuring the efficacy of antidepressants
44. Prevalence of civilian trauma and post-traumatic stress disorder in a representative national sample of women
45. Sertraline in the treatment of rape victims with posttraumatic stress disorder
46. Posttraumatic stress disorder: A biopsychological perspective
47. The Mini International Neuropsychiatric Interview (MINI): The development and validation of a structural diagnostic psychiatric interview for DSM-IV and ICD-10
48. A controlled trial of phenelzine in posttraumatic stress disorder
49. One-factor repeated-measures analysis by variance
50. Pharmacotherapy for post-traumatic stress disorder
51. Fluoxetine in posttraumatic stress disorder
52. Post-traumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans